Zhixin Sheng

7PUBLICATIONS
0CO-AUTHORS
Haematological tumoursTe mana wahine (female status)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Nanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 15, 2023
Superiority of ibrutinib plus bendamustine and rituximab in newly diagnosed patients with mantle-cell lymphoma ineligible for intensive therapy: A network meta-analysis.

Zhixin Sheng, Lida Wang

|Oct 13, 2020
An angiosarcoma in the breast associated with Kasabach-Merritt syndrome: Breast Images.

Da Huo, Zhi-Xin Sheng, Gui-Yan Han

|Feb 11, 2020
Comparison of CD4/6 inhibitors, PI3K inhibitors, and mTOR inhibitors for patients with advanced HR+/HER2- Breast cancer: A network meta-analysis of 19 RCTs.

Lida Wang, Huo Da, Xiulian Li

|Dec 13, 2019
CDK4/6 inhibitors plus endocrine therapy improve overall survival in advanced HR+/HER2- breast cancer: A meta-analysis of randomized controlled trials.

Liquan Wang, Shuyan Gao, Dianfang Li

|Aug 25, 2019
Daratumumab added to standard of care in patients with newly diagnosed multiple myeloma: A network meta-analysis.

Wenjun Xu, DianFang Li, Yanhua Sun

|Jun 14, 2017
Association of asthma with coronary heart disease: A meta analysis of 11 trials.

Lida Wang, Shuyan Gao, Mingdong Yu

Pageof 2

Frequent Collaborators